SCYNEXIS, Inc. (SCYX)
NASDAQ: SCYX · IEX Real-Time Price · USD
2.93
+0.04 (1.38%)
At close: Aug 17, 2022 4:00 PM
3.06
+0.13 (4.44%)
After-hours:
Aug 17, 2022 7:27 PM EDT
SCYNEXIS Market Cap
SCYNEXIS has a market cap or net worth of $95.46 million as of August 18, 2022, making it the 5,065th biggest public company in the US. SCYNEXIS's market cap has decreased by -41.19% in one year.
Market Cap
95.46M
Enterprise Value
24.57M
1-Year Change
-41.19%
Ranking
Category
Micro-Cap
Stock Price
$2.93
Market Cap Chart
Since May 2, 2014, SCYNEXIS's market cap has increased from $27.40 million to $95.46 million, an increase of 248.35%. That is a compound annual growth rate of 16.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2022 | 95.46M | 1.38% |
| Aug 16, 2022 | 94.15M | -1.37% |
| Aug 15, 2022 | 95.46M | 2.09% |
| Aug 12, 2022 | 93.50M | 5.90% |
| Aug 11, 2022 | 88.29M | 0.37% |
| Aug 9, 2022 | 87.96M | -6.90% |
| Aug 8, 2022 | 94.48M | 1.40% |
| Aug 5, 2022 | 93.18M | 4.00% |
| Aug 4, 2022 | 89.59M | 8.70% |
| Aug 3, 2022 | 82.43M | 0.80% |
| Aug 2, 2022 | 81.77M | 3.72% |
| Aug 1, 2022 | 78.84M | 4.76% |
| Jul 29, 2022 | 75.26M | -2.94% |
| Jul 28, 2022 | 77.54M | 8.18% |
| Jul 27, 2022 | 71.67M | 1.85% |
| Jul 26, 2022 | 70.37M | 0.47% |
| Jul 25, 2022 | 70.05M | -1.83% |
| Jul 22, 2022 | 71.35M | 2.34% |
| Jul 21, 2022 | 69.72M | -4.89% |
| Jul 20, 2022 | 73.30M | 6.13% |
| Jul 19, 2022 | 69.07M | 2.42% |
| Jul 18, 2022 | 67.44M | 0.49% |
| Jul 15, 2022 | 67.11M | 12.57% |
| Jul 14, 2022 | 59.62M | -3.68% |
| Jul 13, 2022 | 61.90M | -0.52% |
View and export this data all the way back to 2014.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition
Related Stocks
| Company | Market Cap |
|---|---|
| Decibel Therapeutics | 109.09M |
| Adamis Pharmaceuticals | 49.51M |
| Bolt Biotherapeutics | 76.41M |
| Bionomics | 53.46M |
| Qilian International Holding Group | 50.05M |
| Oncolytics Biotech | 73.46M |
| Rain Therapeutics | 170.81M |
| NantHealth | 61.10M |
| Codiak BioSciences | 52.35M |
| Novo Integrated Sciences | 54.06M |